Tag: Kiromic Biopharma, Inc. Trademarks

Navigating the complex world of IP law

PROCEL – US Trademark 97484095 of Kiromic Biopharma, Inc.

PROCEL (U.S. Trademark Serial Number 97484095) is a United States trademark of Kiromic Biopharma, Inc.. The goods and services include: Biopharmaceutical preparations; Biopharmaceutical preparations in the nature of T-cell allogenic therapies; Cell therapies for use in oncology, immunology, and immuno-oncology; Therapeutic agents for targeting tumors; Biological components, namely genetically engineered T-cells, being a component in…
Read more

ISOCEL – US Trademark 97484087 of Kiromic Biopharma, Inc.

ISOCEL (U.S. Trademark Serial Number 97484087) is a United States trademark of Kiromic Biopharma, Inc.. The goods and services include: Biopharmaceutical preparations; Biopharmaceutical preparations in the nature of T-cell allogenic therapies; Cell therapies for use in oncology, immunology, and immuno-oncology; Therapeutic agents for targeting tumors; Biological components, namely genetically engineered T-cells, being a component in…
Read more

KIROMIC – US Trademark 97484081 of Kiromic Biopharma, Inc.

KIROMIC (U.S. Trademark Serial Number 97484081) is a United States trademark of Kiromic Biopharma, Inc.. The goods and services include: The mark consists of the word KIROMIC and the letter O of the word represents a sun. Pharmaceutical, biologic, and biopharmaceutical preparations; Biopharmaceutical preparations, cell therapies, and gene therapies for preventing, managing, and treating diseases…
Read more

KIROMIC – US Trademark 97484071 of Kiromic Biopharma, Inc.

KIROMIC (U.S. Trademark Serial Number 97484071) is a United States trademark of Kiromic Biopharma, Inc.. The goods and services include: Pharmaceutical, biologic, and biopharmaceutical preparations; Biopharmaceutical preparations, cell therapies, and gene therapies for preventing, managing, and treating diseases and disorders in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations in the nature of T-cell allogenic therapies; Biological…
Read more